Companies Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics (IMDX): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Email me Insight Molecular Diagnostics Inc.’s executive pay brief as a PDF
It arrives in about 2 minutes, with every figure cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $724,910FY2023
- $786,077FY2024
- $2,594,786FY2025
CEO total pay was $2,594,786 in fiscal 2025, up from $786,077 in fiscal 2024.
FY2025: salary $472,293 · bonus $184,675 · stock awards $599,999 · option awards $1,332,000
Order IMDX
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.
Executives and directors
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Joshua Riggs | $472,293 | $184,675 | $599,999 | $1,332,000 | $0 | $0 | $5,819 | $2,594,786 |
| President and Chief Executive Officer | ||||||||
| Andrea James | 367,355 | 152,293 | 359,998 | 782,550 | 0 | 0 | 16,930 | 1,679,126 |
| Chief Financial Officer | ||||||||
| James Liu | 221,804 | 68,311 | 59,997 | 91,740 | 0 | 0 | 13,138 | 454,990 |
| VP of Accounting, Controller, Treasurer & Principal Accounting Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Joshua Riggs | $2,594,786 | $786,077 | $724,910 | ↑ +1,808,709 |
| Andrea James | 1,679,126 | 758,863 | — | ↑ +920,263 |
| James Liu | 454,990 | 303,928 | 304,513 | ↑ +151,062 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Attract, motivate and retain highly-qualified executive officers in a competitive market; provide compensation to our executives that are competitive and reward the achievement of challenging business objectives; and align our executive officers' interests with those of our shareholders by providing a significant portion of total compensation in the form of equity awards.
| CEO STI target (% of salary) | 50% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Frederic W. Cook & Co., Inc. |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | false |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Joshua Riggs | Option | 322 | 7.8 | — |
| James Liu | Option | 702 | 17.74 | — |
| James Liu | Option | 951 | 9.26 | — |
| James Liu | Option | 3,888 | 3.11 | — |
| Joshua Riggs | Option | 4,291 | 9.26 | — |
| James Liu | Option | 6,042 | 2.76 | — |
| Joshua Riggs | Option | 6,556 | 4.26 | — |
| James Liu | Option | 10,000 | 3.18 | — |
| James Liu | Option | 18,000 | 3.33 | — |
| James Liu | RSU | 18,867 | — | 59,997 |
| Andrea James | RSU | 50,000 | — | 101,500 |
| Joshua Riggs | Option | 54,375 | 2.76 | — |
| Andrea James | RSU | 113,207 | — | 359,998 |
| Andrea James | Option | 125,000 | 2.87 | — |
| Joshua Riggs | RSU | 188,679 | — | 599,999 |
| Andrea James | Option | 235,000 | 3.33 | — |
| Joshua Riggs | Option | 400,000 | 3.33 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Andrew ArnoIndependent · Board Chair | $145,427 | $167,200 | $0 | $0 | $0 | $312,627 |
| Andrew J. LastIndependent | 85,427 | 106,400 | 0 | 0 | 0 | 191,827 |
| Louis E. SilvermanIndependent | 85,427 | 106,400 | 0 | 0 | 0 | 191,827 |
| Joshua RiggsEmployee director | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $85,427 |
|---|---|
| Annual equity retainer | $106,400 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | — |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $316,281 |
| Equity awards (grant-date value) | $380,000 |
| All other compensation | $0 |
| Total cost of the board | $696,281 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Insight Molecular Diagnostics as a peer
Companies that benchmark against IMDX
1 company names IMDX as a compensation peer
- SERA PROGNOSTICS, INC.SERAFY2025
Each company listed discloses IMDX in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named IMDX in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Insight Molecular Diagnostics Inc. | 2025 | Joshua Riggs | $472,293 | $599,999 | $1,332,000 | $0 | $2,594,786 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-11 | 19,199,697 | 26,126 | 19,679 | 99.76% | Passed |
| 2025 | 2025-06-27 | 18,063,639 | 28,647 | 12,010 | 99.78% | Passed |
| 2022 | 2022-07-15 | 36,805,242 | 34,793,766 | 1,188,068 | 51.4% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-06-11 | 99.76%a |
| 2025 | 2025-06-27 | 99.78%b |
| 2022 | 2022-07-15 | 51.4%c |
a. Approved under the standard stated in the filing — “Abstentions will have the same effect as votes "against" this proposal.”.
b. Approved under the standard stated in the filing — “Abstentions will have the same effect as votes "against" this proposal.”.
c. Approved under the standard stated in the filing — “Broker non-votes and abstentions will not affect the outcome of any of the proposals to be voted upon.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (14 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Joshua Riggs. DEF 14A, filed 2026-04-30. Section “Summary Compensation Table” · page 15. As printed: 2,594,786. View filing ↗
- Section 01, Andrea James. DEF 14A, filed 2026-04-30. Section “Summary Compensation Table” · page 15. As printed: 1,679,126. View filing ↗
- Section 01, James Liu. DEF 14A, filed 2026-04-30. Section “Summary Compensation Table” · page 15. As printed: 454,990. View filing ↗
- Section 07, pay ratio. 10-K, filed 2026-03-26. Section “CEO Pay Ratio”. As printed: —. View filing ↗
- Section 08, Andrew Arno. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 312,627. View filing ↗
- Section 08, Andrew J. Last. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 191,827. View filing ↗
- Section 08, Louis E. Silverman. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 191,827. View filing ↗
- Section 08, Joshua Riggs. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-06-17. Item 5.07 · say-on-pay result. As reported: 99.76% (votes for as printed: 19,199,697). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-07-02. Item 5.07 · say-on-pay result. As reported: 99.78% (votes for as printed: 18,063,639). View filing ↗
- Section 06, 2022 vote. Form 8-K, filed 2022-07-21. Item 5.07 · say-on-pay result. As reported: 51.4%. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 316,281 + equity 380,000 + all other 0 = 696,281, summed across the director compensation table rows.
- Insight Molecular Diagnostics Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in Insight Molecular Diagnostics Inc.'s own proxy. As printed: 2,594,786. View filing ↗